75 related articles for article (PubMed ID: 16448705)
1. NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis.
Cross AH; Ramsbottom MJ; Lyons JA
J Neuroimmunol; 2006 Apr; 173(1-2):79-86. PubMed ID: 16448705
[TBL] [Abstract][Full Text] [Related]
2. Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response.
Kahl KG; Schmidt HH; Jung S; Sherman P; Toyka KV; Zielasek J
Neurosci Lett; 2004 Mar; 358(1):58-62. PubMed ID: 15016434
[TBL] [Abstract][Full Text] [Related]
3. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
4. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells.
Bebo BF; Schuster JC; Vandenbark AA; Offner H
J Immunol; 1999 Jan; 162(1):35-40. PubMed ID: 9886367
[TBL] [Abstract][Full Text] [Related]
5. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.
Xiao BG; Ma CG; Xu LY; Link H; Lu CZ
Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713
[TBL] [Abstract][Full Text] [Related]
6. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.
Wheeler RD; Zehntner SP; Kelly LM; Bourbonnière L; Owens T
Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and TNFalpha effects in experimental autoimmune encephalomyelitis demyelination.
Farias AS; de la Hoz C; Castro FR; Oliveira EC; Ribeiro dos Reis JR; Silva JS; Langone F; Santos LM
Neuroimmunomodulation; 2007; 14(1):32-8. PubMed ID: 17700038
[TBL] [Abstract][Full Text] [Related]
8. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells.
Meiron M; Zohar Y; Anunu R; Wildbaum G; Karin N
J Exp Med; 2008 Oct; 205(11):2643-55. PubMed ID: 18852294
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis.
Brenner T; Brocke S; Szafer F; Sobel RA; Parkinson JF; Perez DH; Steinman L
J Immunol; 1997 Mar; 158(6):2940-6. PubMed ID: 9058833
[TBL] [Abstract][Full Text] [Related]
10. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
11. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
12. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice.
Ding M; Zhang M; Wong JL; Rogers NE; Ignarro LJ; Voskuhl RR
J Immunol; 1998 Mar; 160(6):2560-4. PubMed ID: 9510151
[TBL] [Abstract][Full Text] [Related]
13. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene.
Fenyk-Melody JE; Garrison AE; Brunnert SR; Weidner JR; Shen F; Shelton BA; Mudgett JS
J Immunol; 1998 Mar; 160(6):2940-6. PubMed ID: 9510198
[TBL] [Abstract][Full Text] [Related]
14. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
15. L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis.
Uboldi C; Döring A; Alt C; Estess P; Siegelman M; Engelhardt B
Eur J Immunol; 2008 Aug; 38(8):2156-67. PubMed ID: 18651702
[TBL] [Abstract][Full Text] [Related]
16. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
17. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
Zhang X; Reddy J; Ochi H; Frenkel D; Kuchroo VK; Weiner HL
Int Immunol; 2006 Apr; 18(4):495-503. PubMed ID: 16540527
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide, a mediator of inflammation, suppresses tumorigenesis.
Hussain SP; Trivers GE; Hofseth LJ; He P; Shaikh I; Mechanic LE; Doja S; Jiang W; Subleski J; Shorts L; Haines D; Laubach VE; Wiltrout RH; Djurickovic D; Harris CC
Cancer Res; 2004 Oct; 64(19):6849-53. PubMed ID: 15466171
[TBL] [Abstract][Full Text] [Related]
19. Resident microglia from adult mice are refractory to nitric oxide-inducing stimuli due to impaired NOS2 gene expression.
Brannan CA; Roberts MR
Glia; 2004 Nov; 48(2):120-31. PubMed ID: 15378654
[TBL] [Abstract][Full Text] [Related]
20. T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice.
Engelmann S; Togni M; Thielitz A; Reichardt P; Kliche S; Reinhold D; Schraven B; Reinhold A
J Immunol; 2013 Nov; 191(10):4950-9. PubMed ID: 24101551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
